Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in …
Over the last 12 months, insiders at Pulse Biosciences, Inc. have bought $9.77M and sold $0 worth of Pulse Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Pulse Biosciences, Inc. have bought $25.03M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: DUGGAN ROBERT W () — $28.64M. Levinson Mitchell E. (Chief Strategy Officer) — $105,090. Barrett Burke Thomas (President and CEO) — $85,600.
The last purchase of 10,000 shares for transaction amount of $85,600 was made by Barrett Burke Thomas (President and CEO) on 2024‑05‑20.
2024-05-20 | President and CEO | 10,000 0.0181% | $8.56 | $85,600 | +90.75% | |||
2023-12-12 | 17,999 0.0321% | $9.15 | $164,691 | +10.39% | ||||
2023-12-11 | 90,118 0.1681% | $9.36 | $843,504 | +13.88% | ||||
2023-12-08 | 116,656 0.2146% | $9.54 | $1.11M | +8.32% | ||||
2023-12-07 | 74,852 0.1352% | $9.19 | $687,890 | +10.96% | ||||
2023-12-06 | 82,813 0.1516% | $9.06 | $750,286 | +14.00% | ||||
2023-12-05 | 66,021 0.1193% | $9.34 | $616,636 | +10.43% | ||||
2023-12-04 | 27,000 0.0505% | $10.38 | $280,260 | -0.10% | ||||
2023-12-01 | 45,600 0.0819% | $9.07 | $413,592 | +11.83% | ||||
2023-11-30 | 152,944 0.2765% | $9.06 | $1.39M | +12.14% | ||||
2023-11-29 | 218,600 0.4025% | $9.38 | $2.05M | +9.58% | ||||
2023-11-28 | 124,397 0.2339% | $8.98 | $1.12M | +15.45% | ||||
2023-11-17 | 20,241 0.037% | $6.10 | $123,470 | +62.91% | ||||
2023-11-16 | Chief Executive Officer | 5,393 0.0102% | $6.52 | $35,156 | +58.95% | |||
2023-11-15 | Chief Strategy Officer | 17,800 0.0298% | $5.90 | $105,090 | +54.67% | |||
2023-05-09 | 10.02M 21.7052% | $6.51 | $65.25M | -9.70% | ||||
2022-10-07 | Chief Strategy Officer | 30,780 0.1025% | $2.27 | $69,908 | +96.52% | |||
2022-09-30 | Chief Executive Officer | 6,500 0.0192% | $2.30 | $14,950 | +62.61% | |||
2021-06-30 | 3.05M 10.2958% | $16.40 | $50M | -9.36% | ||||
2020-06-23 | director | 1,193 0.0055% | $10.70 | $12,767 | +63.04% |
DUGGAN ROBERT W | 36984179 60.1206% | $18.07 | 44 | 0 | +1.23% | |
Levinson Mitchell E. | Chief Strategy Officer | 73027 0.1187% | $18.07 | 3 | 0 | +57.59% |
Danahy Kevin Patrick | Chief Executive Officer | 35887 0.0583% | $18.07 | 2 | 0 | +62.61% |
Barrett Burke Thomas | President and CEO | 10000 0.0163% | $18.07 | 1 | 0 | |
Zanganeh Maky | director | 106767 0.1736% | $18.07 | 17 | 0 | +19.34% |
BlackRock | $9.1M | 1.71 | 1.04M | -2.51% | -$234,542.86 | <0.0001 | |
The Vanguard Group | $7.38M | 1.38 | 847,212 | +28.76% | +$1.65M | <0.0001 | |
Bank of America | $6.79M | 1.27 | 779,552 | -2.72% | -$189,782.19 | <0.01 | |
Geode Capital Management | $3.41M | 0.64 | 390,959 | +3.08% | +$101,918.82 | <0.0001 | |
State Street | $3.05M | 0.57 | 349,740 | +12.99% | +$350,316.15 | <0.0001 |